Le terapie di supporto in oncologia

Translated title of the contribution: Supportive care in oncology

P. Olmi, C. Fallai, G. Ausili-Cefaro, L. Marmiroli

Research output: Contribution to journalArticle

Abstract

It is extremely important to deliver treatments, both in medical oncology and in radiation oncology, in compliance with the due dose intensity, in order to achieve the best results in terms of clinical response and local control and, often, also in terms of survival. Supportive care is one of the tools for the achievement of this goal, permitting the delivery of aggressive therapies and the improvement of Quality of Life. It is the aim of the Tsonc study to evaluate what the main therapeutic trend is, on the ground of a survey performed in 105 medical oncology, radiation oncology, and haematology centres. For this assessment the WHO/INH and RTOG common toxicity criteria were adopted, even knowing that these score systems had been developed for reporting acute/subacute toxicity and not to choose the therapeutic approach. However, these scales give us the possibility to refer to highly validated systems and provide participants with a common language. Thirty-two items of toxicity were listed, and each item included 2 to 4 degrees of severity so to report supportive care accordingly. The present paper reports the criteria of choice of the scales and symptoms and the schedule of the queries.

Original languageItalian
JournalTumori
Volume84
Issue number6 SUPPL. 2
Publication statusPublished - 1998

Fingerprint

Radiation Oncology
Medical Oncology
Hematology
Appointments and Schedules
Language
Therapeutics
Quality of Life
Surveys and Questionnaires

ASJC Scopus subject areas

  • Cancer Research

Cite this

Olmi, P., Fallai, C., Ausili-Cefaro, G., & Marmiroli, L. (1998). Le terapie di supporto in oncologia. Tumori, 84(6 SUPPL. 2).

Le terapie di supporto in oncologia. / Olmi, P.; Fallai, C.; Ausili-Cefaro, G.; Marmiroli, L.

In: Tumori, Vol. 84, No. 6 SUPPL. 2, 1998.

Research output: Contribution to journalArticle

Olmi, P, Fallai, C, Ausili-Cefaro, G & Marmiroli, L 1998, 'Le terapie di supporto in oncologia', Tumori, vol. 84, no. 6 SUPPL. 2.
Olmi P, Fallai C, Ausili-Cefaro G, Marmiroli L. Le terapie di supporto in oncologia. Tumori. 1998;84(6 SUPPL. 2).
Olmi, P. ; Fallai, C. ; Ausili-Cefaro, G. ; Marmiroli, L. / Le terapie di supporto in oncologia. In: Tumori. 1998 ; Vol. 84, No. 6 SUPPL. 2.
@article{f1dc4596a2a04cbeb32980b917197302,
title = "Le terapie di supporto in oncologia",
abstract = "It is extremely important to deliver treatments, both in medical oncology and in radiation oncology, in compliance with the due dose intensity, in order to achieve the best results in terms of clinical response and local control and, often, also in terms of survival. Supportive care is one of the tools for the achievement of this goal, permitting the delivery of aggressive therapies and the improvement of Quality of Life. It is the aim of the Tsonc study to evaluate what the main therapeutic trend is, on the ground of a survey performed in 105 medical oncology, radiation oncology, and haematology centres. For this assessment the WHO/INH and RTOG common toxicity criteria were adopted, even knowing that these score systems had been developed for reporting acute/subacute toxicity and not to choose the therapeutic approach. However, these scales give us the possibility to refer to highly validated systems and provide participants with a common language. Thirty-two items of toxicity were listed, and each item included 2 to 4 degrees of severity so to report supportive care accordingly. The present paper reports the criteria of choice of the scales and symptoms and the schedule of the queries.",
keywords = "Cancer treatment, Internet, Supportive care",
author = "P. Olmi and C. Fallai and G. Ausili-Cefaro and L. Marmiroli",
year = "1998",
language = "Italian",
volume = "84",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6 SUPPL. 2",

}

TY - JOUR

T1 - Le terapie di supporto in oncologia

AU - Olmi, P.

AU - Fallai, C.

AU - Ausili-Cefaro, G.

AU - Marmiroli, L.

PY - 1998

Y1 - 1998

N2 - It is extremely important to deliver treatments, both in medical oncology and in radiation oncology, in compliance with the due dose intensity, in order to achieve the best results in terms of clinical response and local control and, often, also in terms of survival. Supportive care is one of the tools for the achievement of this goal, permitting the delivery of aggressive therapies and the improvement of Quality of Life. It is the aim of the Tsonc study to evaluate what the main therapeutic trend is, on the ground of a survey performed in 105 medical oncology, radiation oncology, and haematology centres. For this assessment the WHO/INH and RTOG common toxicity criteria were adopted, even knowing that these score systems had been developed for reporting acute/subacute toxicity and not to choose the therapeutic approach. However, these scales give us the possibility to refer to highly validated systems and provide participants with a common language. Thirty-two items of toxicity were listed, and each item included 2 to 4 degrees of severity so to report supportive care accordingly. The present paper reports the criteria of choice of the scales and symptoms and the schedule of the queries.

AB - It is extremely important to deliver treatments, both in medical oncology and in radiation oncology, in compliance with the due dose intensity, in order to achieve the best results in terms of clinical response and local control and, often, also in terms of survival. Supportive care is one of the tools for the achievement of this goal, permitting the delivery of aggressive therapies and the improvement of Quality of Life. It is the aim of the Tsonc study to evaluate what the main therapeutic trend is, on the ground of a survey performed in 105 medical oncology, radiation oncology, and haematology centres. For this assessment the WHO/INH and RTOG common toxicity criteria were adopted, even knowing that these score systems had been developed for reporting acute/subacute toxicity and not to choose the therapeutic approach. However, these scales give us the possibility to refer to highly validated systems and provide participants with a common language. Thirty-two items of toxicity were listed, and each item included 2 to 4 degrees of severity so to report supportive care accordingly. The present paper reports the criteria of choice of the scales and symptoms and the schedule of the queries.

KW - Cancer treatment

KW - Internet

KW - Supportive care

UR - http://www.scopus.com/inward/record.url?scp=0032460971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032460971&partnerID=8YFLogxK

M3 - Articolo

C2 - 10083887

AN - SCOPUS:0032460971

VL - 84

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6 SUPPL. 2

ER -